CoChat

Safety assessment of the Clostridium butyricum MIYAIRI 588 ® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo

Isa, K, Oka, K, Beauchamp, N, Sato, M, Wada, K, Ohtani, K, Nakanishi, S, McCartney, E, Tanaka, M, Shimizu, T, Kamiya, S, Kruger, C, Takahashi, M · 2016 · Human & Experimental Toxicology

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Probiotics are live microorganisms ingested for the purpose of conferring a health benefit on the host. Development of new probiotics includes the need for safety evaluations that should consider factors such as pathogenicity, infectivity, virulence factors, toxicity, and metabolic activity. Clostridium butyricum MIYAIRI 588 ® (CBM 588 ® ), an anaerobic spore-forming bacterium, has been developed as a probiotic for use by humans and food animals. Safety studies of this probiotic strain have been conducted and include assessment of antimicrobial sensitivity, documentation of the lack of Clostridium toxin genes, and evaluation of CBM 588 ® on reproductive and developmental toxicity in a rodent model. With the exception of aminoglycosides, to which anaerobes are intrinsically resistant, CBM 588 ® showed sensitivity to all antibiotic classes important in human and animal therapeutics. In addition, analysis of the CBM 588 ® genome established the absence of genes for encoding for α, β, or ε toxins and botulin neurotoxins types A, B, E, or F. There were no deleterious reproductive and developmental effects observed in mice associated with the administration of CBM 588 ® . These data provide further support for the safety of CBM 588 ® for use as a probiotic in animals and humans.

Overview

Integrity signals

Registry

Crossref · 10.1177/0960327115607372

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 16

  1. Pattani R, 2013, Open Med, 7, e56
  2. Barkay T, 2005, ASM News, 71, 412
  3. 10.1128/mr.55.4.621-648.1991 · doi:10.1128/mr.55.4.621-648.1991 · Paper page
  4. EU. Commission Regulation (EC) No 903/2009 of 28 September 2009 concerning the authorisation of the preparation of Clostridium butyricum MIYAIRI 588 (FERM-P 1467) as a feed additive for chickens for fattening (holder of authorisation Miyarisan Pharmaceutical Co. Ltd, represented by Mitsui & Co. Deutschland GmbH). Official Journal of the European Union L02/10, http://eur-lex.europa.eu (2009, accessed 1 April 2015).
  5. EU. Commission Implementing Regulation (EU) No 373/2011 of 15 April 2011 concerning the authorisation of the preparation of Clostridium butyricum FERM-BP 2789 as a feed additive for minor avian species except laying birds, weaned piglets and minor porcine species (weaned) and amending Regulation (EC) No 903/2009 (holder of authorisation Miyarisan Pharmaceutical Co. Ltd, represented by Miyarisan Pharmaceutical Europe S.L.U.). Official Journal of the European Union L02/10, http://eur-lex.europa.eu (2011, accessed 1 April 2015).
  6. EU. Commission Implementing Regulation (EU) No 1108/2014 of 20 October 2014 concerning the authorisation of a preparation of Clostridium butyricum (FERM BP-2789) as a feed additive for turkeys for fattening and turkeys reared for breeding (holder of authorisation Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U.). Official Journal of the European Union L301/16, http://eur-lex.europa.eu (2014, accessed 1 April 2015).
  7. EU. Commission Implementing Decision of 11 December 2014 authorising the placing on the market of Clostridium butyricum (CBM 588) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council. Official Journal of the European Union L359/153, http://eur-lex.europa.eu (2014, accessed 1 April 2015).
  8. Yuzawa T, 1987, Pharmacometrics, 34, 215
  9. Yuzawa T, 1987, Pharmacometrics, 34, 223
  10. Yuzawa T, 1987, Pharmacometrics, 33, 683
  11. CLSI, 2012, Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard – eighth edition. CLSI document M11-A8
  12. CLSI, 2012, Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second informational Supplement. CLSI document M100-S22
  13. Japan Ministry of Health and Welfare, Pharmaceutical guidelines for teratogenicity and reproductive toxicity studies
  14. EFSA, 2012, EFSA J, 10, 2740
  15. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), 2009, EFSA J, 1039, 1
  16. Wang W, 2000, Jpn Pharmacol Ther, 28, 999

Cited by

See all 58

Metadata

Authors
Isa, K., Oka, K., Beauchamp, N., Sato, M., Wada, K., Ohtani, K., Nakanishi, S., McCartney, E., Tanaka, M., Shimizu, T., Kamiya, S., Kruger, C., & Takahashi, M.
Affiliations
  • Miyarisan Pharmaceutical Co., Ltd. (Japan) (JP)
  • Spherix Consulting, Rockville, MD, USA
  • Kanazawa University (JP)
  • Pen & Tec Consulting, Barcelona, Spain
  • Kyorin University (JP)
Corresponding author
Takahashi, M
Venue
Human & Experimental Toxicology
Published
2016-07-20
Volume
35
Issue
8
Pages
818-832
ISSN
  • 0960-3271 (ISSN-L)
  • 1477-0903
OpenAlex
W2267159929
Cited by
52
References
45
Citations by year
2026: 5 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 5 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 1
FWCI
3.12
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Human & Experimental Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Miyarisan Pharmaceutical
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Keywords
probiotic safety, antimicrobial susceptibility, botulinum toxin, reproductive toxicity, developmental toxicity, teratogenicity, anaerobic spore-forming bacteria, aminoglycoside resistance
MeSH terms
Abnormalities, Drug-Induced, Animals, Anti-Bacterial Agents, Bacterial Toxins, Botulinum Toxins, Enterotoxins, Female, Male, Mice, Inbred ICR, Microbial Sensitivity Tests, Neurotoxins, Pregnancy, Reproduction, Probiotics, Drug Resistance, Bacterial, Clostridium butyricum, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety assessment of the Clostridium butyricum MIYAIRI 588 ® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo. https://app.cochat.ai/papers/10.1177/0960327115607372
The paper
Isa, K., Oka, K., Beauchamp, N., Sato, M., Wada, K., Ohtani, K., Nakanishi, S., McCartney, E., Tanaka, M., Shimizu, T., Kamiya, S., Kruger, C., & Takahashi, M. (2016). Safety assessment of the Clostridium butyricum MIYAIRI 588 ® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo. Human & Experimental Toxicology. https://doi.org/10.1177/0960327115607372

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.